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Background: The multi-meric calcium/calmodulin-dependent protein kinase II (CaMKII) is the main CaMK in
skeletal muscle and its expression increases with endurance training. CaMK family members are implicated in
contraction-induced regulation of calcium handling, fast myosin type IIA expression and mitochondrial biogenesis.
The objective of this study was to investigate the role of an increased CaMKII content for the expression of the
contractile and mitochondrial phenotype in vivo. Towards this end we attempted to co-express alpha- and beta-CaMKII
isoforms in skeletal muscle and characterised the effect on the contractile and mitochondrial phenotype.
Results: Fast-twitch muscle m. gastrocnemius (GM) and slow-twitch muscle m. soleus (SOL) of the right leg of 3-month
old rats were transfected via electro-transfer of injected expression plasmids for native α/β CaMKII. Effects were
identified from the comparison to control-transfected muscles of the contralateral leg and non-transfected muscles.
α/β CaMKII content in muscle fibres was 4-5-fold increased 7 days after transfection. The transfection rate was more
pronounced in SOL than GM muscle (i.e. 12.6 vs. 3.5%). The overexpressed α/β CaMKII was functional as shown through
increased threonine 287 phosphorylation of β-CaMKII after isometric exercise and down-regulated transcripts COXI,
COXIV, SDHB after high-intensity exercise in situ. α/β CaMKII overexpression under normal cage activity accelerated
excitation-contraction coupling and relaxation in SOL muscle in association with increased SERCA2, ANXV and fast
myosin type IIA/X content but did not affect mitochondrial protein content. These effects were observed on a
background of regenerating muscle fibres.
Conclusion: Elevated CaMKII content promotes a slow-to-fast type fibre shift in regenerating muscle but is not
sufficient to stimulate mitochondrial biogenesis in the absence of an endurance stimulus.
Keywords: CaMKII, Skeletal muscle, Plasticity, Excitation, Contraction, MitochondriaBackground
Repeated muscle contractions rely on motoneuron-driven
variations in sarcoplasmic calcium though ryanodine
receptor-mediated release of calcium from the sarcoplasmic
reticulum (SR) and the subsequent re-uptake of calcium via
SERCA channels [1]. The observed magnitude of the
rise in sarcoplasmic calcium varies between slow and
fast muscle types, which suggests it may control the* Correspondence: mflueck@research.balgrist.ch
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unless otherwise stated.contractile characteristics of muscle fibres [2]. However,
this relationship is not fixed and muscle fibre makeup in
SR and contractile proteins demonstrates a certain
degree of plasticity in response to contractile stimuli
[3]. An important feature of repeated muscle work (i.e.
endurance training) is the specific increase in mitochondrial
content; reflecting a compensatory strategy to meet the
energy demand of fibres undergoing frequent rounds of
actin and myosin cross-bridge cycling [4]. In the rat, the
mitochondrial adaptations of exercised skeletal muscle are
associated with a transition of myosin isoform expression
towards a slow-twitch phenotype [5,6]. The observed
transformation of muscle fibre types is associated with
a chronic rise in sarcoplasmic calcium [7-9], which implicatesis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of muscle plasticity.
The calcium/calmodulin-dependent phosphatase
calcineurin and calcium/calmodulin-dependent kinases
(CaMK) are important transducers of calcium signals
towards gene expression [2,10]. The calcineurin-mediated
pathway has been shown to regulate expression of slow
fibre type-related myofibrillar proteins [11-13] and affects
mitochondrial gene expression although calcineurin does
not appear required for exercise-induced mitochondrial
biogenesis [14-16]. By contrast, CaMK activation has been
implied to regulate mitochondrial biogenesis [9,17,18],
type IIA myosin heavy chain (MHCIIA) expression
[19,20] and calcium re-uptake into the SR in slow type
muscle fibres [21].
However, the current understanding of the physiological
role of CaMK holoenzymes in whole muscle is incomplete,
as previous studies rely on short-term inhibition studies
with pharmacological agents in single muscle fibres [22] or
the overexpression of a CaMKIV mutant which is not
expressed in skeletal muscle [23] and has lost its
calcium-dependent regulation [18]. CaMKII is the main
CaMK isoform in skeletal muscle. Importantly, however,
the effects of CaMKII on the expression of genes that
underlie muscle plasticity have - apart from the study of
the glucose transporter GLUT4 [24] - not been addressed.
CaMKII operates as a hetero-meric phospho-transferase
which can decode calcium transients through auto-
phosphorylation at threonine-287 ([2,25,26]). Threonine-287
phosphorylation of CaMKII is increased after acute
exercise in rats and humans [27,28], indicating that
CaMKII is part of the signalling pathways integrating
the effects of exercise on muscle structure and function
(reviewed by [2,29]). These findings emphasize that
CaMKII activation is firmly associated with the regulation
of the oxidative muscle phenotype with contractile
paradigms [2,30]. This is corroborated by the concomitant
increase in CaMKII and mitochondrial ATP synthase
expression with endurance exercise training [31,32].
However, the question remains to which extent contractile
features, as shown by CaMK inhibition in vitro [19,20],
depend on CaMKII in vivo, and to which extent down-
stream effects of CaMKII-mediated calcium sensing
would be differently affected between contractile muscle
phenotypes [33,34].
We hypothesized that the content of hetero-multimeric
CaMKII controls the mitochondrial and contractile
phenotype of skeletal muscle and that this would take
place in both slow-twitch m. soleus (SOL) and fast-twitch
m. gastrocnemius (GM). We tested this assumption by
assessing the effects of the co-overexpression of native
alpha- and beta-CaMKII isoforms, with similar substrate
specificity and structure as the skeletal muscle CaMKII
isoforms [35,36] on selected protein markers of thecontractile and mitochondrial phenotype. Additionally,
the corresponding transcript response to high-intensity
exercise in situ was measured along with functional
characteristics of the targeted SOL and GM muscles.
Because the muscles under investigation show fibre
recruitment during self-initiated locomotion [37] we
assumed that the effect of CaMKII overexpression
would manifest under normal cage activity without an
imposed contraction protocol. Control experiments were
carried out to quantify the extent of muscle regeneration
being associated with the selected electro-transfer method
to produce overexpression from injected expression
plasmids [38-40].
Results
CaMKII overexpression and phosphorylation in skeletal
muscle
α/β-CaMKII-transfection increased protein levels of
α- and β-CaMKII isoforms at 50 and 60 kDa, respectively,
compared to control-transfected SOL muscle (Figure 1A).
In vitro experiments demonstrated Ca2+/CaM-dependent
phosphorylation of the introduced β CaMKII (Figure 1C).
Overexpression of α/β CaMKII could be detected in
12.6% of fibres in SOL muscle and at a lower level, i.e.
3.5%, in GM muscle (p = 0.002). α- and β-CaMKII content
was increased at the level of total protein in SOL muscle
(Figure 1D/E). Fibres in SOL and GM muscle which
demonstrated elevated CaMKII expression after the
transfection of α/β CaMKII plasmid had 5.3 ? 0.8 and
4.0 ? 0.5 fold increased CaMKII levels, respectively.
Mean cross sectional area (MCSA) of the transfected
muscle fibres was lower than the non-transfected fibres
in the α/β CaMKII-transfected SOL muscle (transfected
vs. non-transfected muscle fibre: 2675 ? 132 vs. 3706 ?
86 μm2; p = 0.001).
α-and β-CaMKII co-overexpression shifts gene expression
towards a fast phenotype with enhanced calcium
handling
Factorial analysis of the paired data revealed a main
effect (p < 0.05) of the co-overexpression of the native
α- and β-CaMKII isoforms on the contractile parameters
time-to-peak-twitch force (-16%) and half-relaxation-time
(-15%) for the combined data from SOL and GM muscle
(Figure 2). In SOL muscle alone, a trend for a shortened
half-relaxation-time was identified. Maximum twitch
force and maximum tetanic force, and fatigability of
tetanic force, did not differ between control- and α/β
CaMKII-transfected GM and SOL.
We assessed the effect of α/β CaMKII overexpression
on the levels of proteins associated with the acceleration
of muscle contraction (i.e. MHCIIA/IIX and IIB) and
relaxation (SERCA2, ANXV; [4, 67]). This analysis was
limited to SOL, because of the higher transfection efficiency
Figure 1 α/β CaMKII co-overexpression in soleus and gastrocnemius muscle. A) Immunoblot of homogenate from a control-transfected
(1,3) and α/β CaMKII-transfected (2,4) GM (1,2) and SOL (3,4) and muscle pairs after detection with antibody against pan-CaMKII. B, C) Immunoblot with
pan-CaMKII (B) and pThr287-CaMKII antibody (C) of in vitro kinase reactions of homogenates from a α/β CaMKII-plasmid injected and porated soleus
muscle after incubation in conditions: 1) suppressing (EGTA) and 2) allowing (2, Ca2+/CaM) calcium/calmodulin dependent autophosphorylation.
Loading controls of the respective Ponceau S-stained membrane visualizing the skeletal α actin band are shown below. Arrows indicate the position
of the bands corresponding to Calcium/Calmodulin-inducible kinase II isoforms. α and β correspond to the overexpressed CaMKII isoforms. D, E) Bar
graph showing the mean + SE of α/β CaMKII protein content in control-porated (light grey filled bar) and porated and α/β CaMKII co-transfected
(light grey filled bar) soleus (D) and gastrocnemius medialis (E) muscle. +, 0.05≤ p <0.10 vs. control-porated muscle, respectively. n = 4.
Figure 2 Contractile effects of α/β CaMKII co-overexpression. A) Mean + SE of values for the contractile parameters time-to-peak-twitch force
(TTP), half-relaxation time (HRT), maximum twitch force (Ftwitch) and maximum tetanic force (Fmax) for the SOL and GM muscle combined being
subjected to control-transfection (light grey filled bar) or α/β CaMKII-transfection (dark grey filled bar). Values reflect values relative to the average
seen in non-transfected muscle (n = 7). *, p ≤0.05 vs. control-transfected muscle. Repeated ANOVA with post hoc test of Fisher (n = 11). B) Scatter
plot of mean + SE of force values of fifty paced tetanic contractions in non-transfected, control-transfected, and α/β CaMKII-transfected GM
muscle. n = 6-9 per group.
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three proteins, myosin heavy chain isoforms IIA/IIX,
SERCA2 and ANXV, was increased in SOL muscle
compared to contra-lateral control-transfected SOL
muscle (Figures 3 and 4).
Examples of the immunofluorescence detection of
CaMKII, MHCI and MHCII are shown in Figure 4A-C. A
larger fraction of CaMKII-transfected fibres expressed
MHCII than non-transfected fibres (0.36 vs. 0.18; p = 0.0008,
Chi2-Test). Quantification of the co-staining of CaMKII and
SERCA2 (Figure 4D/E) revealed a significantly higher
staining intensity of SERCA2 in CaMKII-overexpressing
SOL fibres compared to that in non-transfected fibres of
the same muscle (Figure 4F).
Protein levels for constituents of the oxidative
phosphorylation chain were not affected by α/β CaMKII
overexpression (Figure 5A). We assessed whether overex-
pression of α/β CaMKII was sufficient to increase COXIV
protein expression at the fibre level (Figure 5C). COXIV
staining intensity in transfected muscles did not differ
between CaMKII-overexpressing and non-transfected
fibres in SOL muscle (Figure 5D).
Immunofluorescent signals in muscle fibres were
also quantified in GM muscle. In this muscle, COXIVFigure 3 α/β CaMKII co-overexpression increases MHCIIA/X but not m
heavy chain (MHCII) (A) and ANXV (C) in homogenate from a control-transfec
control visualizing skeletal alpha actin (skaa). B, D) Bar graph visualising the m
(D) in control-transfected (light grey filled bar) and α/β CaMKII-transfected (da
(Wilcoxon test).signal intensities did not differ as a function of α/β
CaMKII overexpression (Figure 5D), but a larger fraction
of CaMKII-transfected than non-transfected muscle fibres
demonstrated MHCII staining (0.77 vs. 0.12, p = 0.048;
Chi2-Test).
CaMKII signalling after paced contractions in situ
We investigated whether α/β CaMKII-transfected SOL
muscle retains responsiveness for contraction-induced
CaMKII signalling. Paced isometric exercise in situ
increased threonine-287 phosphorylation of β CaMKII
(Figure 6A). Concomitantly, muscle fibres with ele-
vated CaMKII content demonstrated increased signal
for pThr287-CaMKII (Figure 6B-E). RT-PCR experiments
demonstrated reduced transcript levels of mitochondrial
factors (COXI, COXIV, SDHB) and SERCA2A immediately
after high-intensity exercise (Figure 5B).
Transfection affects muscle contractility
Compared to non-transfected muscle, twitch force
(-12%) and maximal tetanic force (-30%) were reduced
and time-to-peak-twitch force (+22%) and half-relaxation-
time (+32%) were prolonged in control-transfected muscle
(Table 1). When values were assessed separately for theitochondrial protein. A, C) Immunodetection of fast type myosin
ted (1) and α/β CaMKII-transfected (2) SOL muscle pair. Below loading
ean + SE of MHCA/IIX and MHC IIB (B) and ANXV protein content
rk grey filled bar) SOL muscle (n = 9). *, p ≤0.05 vs. control-transfected
Figure 4 α/β CaMKII co-overexpression in relation to MHC and SERCA2 expression. A-C) Microscopic field of α/β CaMKII-transfected SOL
muscle stained for CaMKII (A, red), fast MyHCII (B, green) and slow MHCI (C, blue). Corresponding areas are circled. D, E) Microscopic field of an
α/β CaMKII-transfected SOL muscle after staining for CaMKII (red, D) and SERCA2 (yellow, E). F) Bar graph visualizing the mean + SE of SERCA2
levels in transfected (Tf, n = 276) and non-transfected (NTf, n = 221) muscle fibers. *, p ≤0.001.
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were reduced in SOL muscle with control-transfection.
Concomitantly, markers of damage (caveolin 3 mRNA)
and regeneration (myogenin protein, fibres with internal
nuclei) were elevated in SOL muscle 7 days after transfec-
tion (Figure 7).
Discussion
This is the first study that investigates whether increased
CaMKII protein expression affects the skeletal muscle
phenotype in vivo. Transcript measures indicate that
α/β CaMKII signalling down-regulates mitochondrial
gene expression after high-intensity exercise (Figure 5B).
In contrast to our hypothesis, we did not observe
altered expression of mitochondrial protein(s) in α/β
CaMKII-transfected muscle fibres of rats housed
under normal cage activity (Figure 5A/D). By contrast,
twitch contraction and relaxation times were reduced in
α/β CaMKII-transfected muscles (Figure 2) when major
proteins of muscle contraction and relaxation, i.e. MHC
IIA/IIX and SERCA2, were increased (Figures 3A/B and 4).
Regarding contractile features and MHCII expression
in transfected muscle (fibres) the effects of α/β CaMKII
overexpression were comparable in the slow-twitch and
fast-twitch muscle under investigation. Our results suggest
that, in the context of muscle transfection, α/β CaMKII
content regulates the expression of proteins involved in
muscle contraction and relaxation, but not of proteins
involved in mitochondrial biogenesis.Technical considerations
In order to assess the effect of an increase in CaMKII
holoenzymes, we deployed gene electro-transfer with
expression constructs for native α- and β-CaMKII isoforms
with similar substrate specificity and structure as the skel-
etal muscle CaMKII isoforms [35,36]. CaMKII overexpres-
sion was confined to muscle fibres (Figures 4A, 5C and
6B/D), in which CaMKII content was increased 4.0-5.3
fold compared to CaMKII content in non-transfected
fibres. The latter possibly reflects the abundant β M
isoform (Figure 1A; [36,41]). Immunodetection of the
validated protein band for threonine 287-phosphorylated
CaMKII (Figure 1C) demonstrated that the introduced β
CaMKII retained responsiveness for contraction-induced
CaMKII signalling (Figure 6A). The findings imply that the
increased content of native CaMKII resulted in potentially
higher CaMKII activity which is amenable to physiological
regulation during muscle recruitment in vivo. It has been
estimated that motor units in SOL muscles of caged, but
freely moving rats are active for 25-30% during a 24-hour
period [34]. Furthermore, rat SOL is recruited during pos-
tural and slow running activity [37]. Therefore, we expected
transfected fibres in this muscle to be frequently recruited.
We acknowledge, however, that muscle regeneration is
inherent to the selected mode of transfection (Figure 7).
This is of relevance for our finding that mitochondrial
protein levels in α/β CaMKII-transfected SOL muscles
were unaffected because muscle regeneration decreases
mitochondrial enzyme expression and activity [42,43].
Figure 5 Effect of α/β CaMKII co-overexpression on mitochondrial gene expression. A) Bar graph visualising the mean + SE of assessed
mitochondrial proteins in control-transfected (light grey filled bar) and α/β CaMKII-transfected (dark grey filled bar) SOL muscle (n = 6). Representative
examples of detected mitochondrial protein are shown below. *, p ≤0.05 vs. control-transfected (Wilcoxon Test). B) Bar graph of mean + SE of the
differences in expression of selected gene transcripts between α/β CaMKII-transfected and control-transfected SOL muscle (n = 6). * denotes p ≤0.05
vs. control-transfected muscle (T-test). C) Microscopic images visualising the association of the mitochondrial marker, COXIV, with transfected (Tf) and
non-transfected (NTf) fibres in α/β CaMKII-transfected GM and SOL muscle. D) Bar graph showing the mean + SE of COXIV levels in transfected
(n = 54 for GM and n = 38 for SOL) and non-transfected (n = 51 for GM and n = 35 for SOL) muscle fibres. The corresponding p-values are indicated.
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and half-relaxation time in α/β CaMKII-transfected
muscles (Figure 2) support a role of CaMKII content in the
regulation of excitation-contraction coupling in skeletal
muscle. The comparison to non-transfected muscle reveals
that this contractile effect occurred on the background of
reduced contractility with transfection-induced muscle
damage and regeneration (Table 1; Figure 7). Consideringthe broad influence of muscle damage on myogenic
processes and the expression of factors involved in
excitation-contraction coupling [44,45]; a number of
factors are likely involved in correcting the detriment
in contractility by the overexpression of α/β CaMKII. This
potentially includes the calcium channels, SERCA2
and RyR, which control excitation-contraction coupling
via calcium release and re-uptake in the sarcoplasmic
Figure 6 Phosphorylation of overexpressed CaMKII after isometric exercise in situ. A) Example of immunodetected CaMKII (top panel) and
pThr287-CaMKII (bottom) in transfected GM and SOL muscle after 2-minutes of isometric exercise in situ. Endogenous and exogenous (bold font)
CaMKII isoforms are labelled. Red arrows indicate threonine 287 phosphorylated β-CaMKII in lanes loaded with homogenate from stimulated
samples (stim) compared to non-stimulated samples (rest). B, C) Microscopic field of α/β CaMKII-transfected SOL muscle after staining for CaMKII
(red, B) and pThr287-CaMKII (blue, C). D, E) Microscopic field of α/β CaMKII-transfected GM muscle after staining for CaMKII (red, D) and pThr287-CaMKII
(E). Note the congruency of CaMKII and pThr287-CaMKII stained muscle fibres. Scale bar denotes 250 μm.
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channels are regulated by CaMKII-dependent phosphoryl-
ation ([22,46], Hawkins et al., [47,48]). The characterisa-
tion of CaMKII-mediated phosphorylation was not the
focus of this investigation. At present it is therefore
unclear if CaMKII-dependent phosphorylation of SERCA
and RyR played a role in decreasing twitch contraction
and relaxation times in our experiments. Rather we
identify that correction of the detriment in time-to-peak
contraction and half-relaxation time by α/β CaMKII
overexpression was associated with altered expression
of SERCA2 and selected factors involved in excitation-
contraction coupling (i.e. MHCIIA/X, ANXV). The
increased SERCA2 protein levels in SOL were localised to
muscle fibres that overexpress α/β CaMKII (Figure 4D-E).
The localisation of SERCA2 and ANXV to the sarco-
plasmic reticulum [49,50] suggests that the decrease in
half-relaxation time with α/β CaMKII overexpressionTable 1 Effect of α/βCaMKII-transfection vs. controls on contr
SOL
Non-transfected Control-transfected α/βCaMKII-transfec
Ftwitch (mN) 216?9.3 178 ?15
a 174 ?20
Fmax (mN) 1083?57 555 ?57
a 568 ?80
Fatigue (%) 10.5 ?3.6 18.8 ?5.3 22.7 ?5.4
TTP (ms) 105 ?14 133 ?7.9 a 108 ?7.3 b
HRT (ms) 121 ?18 168 ?4.6 a 142 ?6.9 b
Data are shown as mean ? SE. For abbreviations see Figure 2. Fatigue: % decrease
relative to first contraction; a: Main effect of electro-transfer procedure (p<0.05); b: Minvolves adjustments within the sarcoplasmic reticulum of
transfected muscle fibres.
By contrast we observed no effect of α/β CaMKII-
transfection on maximal force production (Figure 2).
Regeneration has been shown to decrease specific force
and increase the ratio of twitch force to tetanic force
[44]. This detriment has been shown to last up to
seven days after injury [43]. Therefore, it may be that
any increase in maximal force was masked by negative
effects of transfection on characteristics that limit
force production with contraction.
Transfection of SOL muscle is associated with the
expression of myosin heavy chain IIA (MHCIIA) in
type I muscle fibres [39]. In this regard it is of interest that
α/β CaMKII overexpression in slow-twitch SOL
muscle further increased MHCIIA/X levels compared
to control-transfected muscle (Figure 3A) and that
the CaMKII-transfected muscle fibres demonstratedactile parameters
GM
ted Non-transfected Control-transfected α/βCaMKII-transfected
2548 ?86 2377 ?175 a 2380 ?178
8864 ?395 7594 ?638 a 8078 ?723
67.5 ?2.1 65.3 ?2.9 67.6 ?2.2
43.0 ?3.3 50.9 ?4.0 a 44.2 ?2.4 b
42.9 ?5.9 54.0 ?6.0 a 46.2 ?3.9 b
in force after the 50 maximal tetanic contractions of the high-intensity exercise,
ain effect of α/βCaMKII overexpression (p<0.05).
Figure 7 Damage and regeneration with electroporation. A, B) Bar graph showing mean + SE of the percentage of fibers with central nuclei
(A) and levels of the damage markers, caveolin 3 and dysferlin mRNA, in non-transfected and control-transfected SOL muscle (B). C, D) Bar graph
of the mean + SE (C) and a representative immunodetection (D) of the myogenic marker myogenin (top), myoD (middle) and the skaa loading control
(bottom) in (from left to right) non-transfected, control-transfected and a/b-transfected muscle (n=8, each). Proteins of interest are indicated with an
arrow respective to the position of molecular weight markers (in kDa). * and **, p-values <0.05 and <0.001 for the indicated differences (unpaired T-test).
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(0.36 vs. 0.18) and GM muscle (0.77 vs. 0.12). The
identified increase in SERCA2 and ANXV content with α/
β CaMKII-overexpression compare to the demonstrated
influence of overexpressed native CaMKII on gene
expression being associated with excitation-contraction
coupling and hypertrophy in cardiac myocytes [51,52].
Our findings are also in accordance with the results of
Allen & Leinwand [19], who demonstrated that the
calcium-ionophore A23187 increased MHCIIA promoter
activity in C2C12 cells, which was attenuated by the
CaMK inhibitor KN62. This raises the hypothesis that an
increase in sarcoplasmic calcium levels in injured muscle
fibres enhances expression of the fast fibre type program,
through a CaMKII-dependent mechanism.
In contrast to our expectations, we observed no
increase in mitochondrial protein (Figure 5A) and fatigue
resistance (Figure 2B) in α/β CaMKII-overexpressing
muscles compared to control-transfected muscles. To the
best of our knowledge, this is the first study investigating
whether increased content of native CaMKII increases the
expression of a mitochondrial protein in any tissue type.
Constitutively active CaMKIV increases mitochondrialbiogenesis when overexpressed from an embryonic
stage onward [18], but this CaMK is not endogen-
ously expressed in skeletal muscle [23,32] and CaMKIV
knock-out mice do not display altered muscle adaptation
in response to training [23]. Whether CaMKIV would
have a similar function in skeletal muscle compared
to CaMKII is questionable, since the two proteins
have different substrate specificity and intracellular
localisation [53-55].
The results demonstrate that increased α/β CaMKII
content is not sufficient to increase mitochondrial gene
expression. We can therefore not rule out the possibility
that CaMKII is required in conjunction with other
signalling pathways for the response to exercise as shown
before for the activity of a GLUT4-enhancer in mouse m.
tibialis anterior [56]. In this regard, we identify that
the reduced mitochondrial and SERCA2 transcript levels
after high-intensity exercise in α/β CaMKII-transfected
SOL muscle (Figure 5B) reproduce the reduced transcript
expression within hour after high-load type of bicycle
exercise [57] which contrasts to the up-regulation of
gene transcripts with low-load endurance type exer-
cise [58]. This suggests that effects of regeneration on
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with insufficient endurance type stimuli in the α/β
CaMKII-transfected muscle of the rats housed under
normal cage activity.Conclusion
Our results support a role for elevated sarcoplasmic
CaMKII content for accelerating muscle contraction and
relaxation in regenerating muscle via effects that include
the enhanced expression of fast myosin heavy chain
and sarcoplasmic reticulum associated SERCA2 and
ANXV protein, but not in mitochondrial biogenesis.
These observations in vivo are the first to point out a
role for quantitative changes in this multi-functional
calcium-dependent enzyme in control of the contractile
muscle phenotype.Methods
Experimental design
Three experimental groups from two phenotypically
distinct muscles (i.e. the fast GM and slow SOL
muscle) were compared in this experiment: group 1:
?α/β CaMKII-transfection?, group 2: ?control-transfection?,
and group 3: ? non-transfected controls? . The comparison of
group 1 vs. 2 allows identifying the feasibility and effect
of CaMKII overexpression, while the comparison of
groups 2 vs. 3. allows conclusions on the effects of
transfection alone.
Transfection of muscle fibres was achieved via intramus-
cular injection of plasmid prior to the application of defined
electric pulses (electro-transfer). Thereby a paired design
was adopted where α/β CaMKII-transfected right SOL and
GM muscles of animals were compared to the respective
contralateral (i.e. left) muscles that were subjected to a
control-transfection.
Effects were assessed seven days after the intervention
through measurements of selected molecular, cellular and
functional parameters. Functional effects were assessed in
situ in intact muscle-tendon preparations (for abbreviations
see Figure 2). The molecular measures included the
quantification of the content in selected proteins using
western blotting/immunodetection and the content of
selected gene transcripts after high-intensity exercise in
situ. The specificity of detecting CaMKII and threonine
287 phosphorylated CaMKII (pThr287-CaMKII) was
assessed based on western blotting and immunodetection of
homogenates from ?control-transfected? and ?α/β CaMKII-
transfected? muscle, and homogenates which were incu-
bated in vitro to assess calcium/calmodulin-dependent
threonine 287 phosphorylation with commercial antibodies.
The cellular specificity of CaMKII overexpression
and downstream effects were assessed by quantifying
immunofluorescent signals as recorded using confocalmicroscopy or by quantifying conventional colorimetric
staining as documented with light microscopy.
Animals
Female Wistar rats were used for the experiments
described here. In situ contraction protocols and the
majority of the electroporation experiments were carried
out at the MOVE Research Institute Amsterdam, VU
University Amsterdam, The Netherlands, and approved by
the local committee on ethics of animal experimentation.
Rat handling and experiments conformed with the Dutch
Research Council? s guide for the care and use of laboratory
animals. Two series of electroporation experiments were
carried out at the Department of Cardiovascular Surgery,
University Hospital Bern, Switzerland. These experi-
ments were carried out according to the permission
of the Animal Care Committee of the Canton of Berne
(Switzerland) and following the recommendations pro-
vided by the European Convention for the protection of
Vertebrate Animals used for Experimental and Scientific
purposes (Strasbourg, 18.III.1986).
Transfection
Plasmid injection followed by electropulsing was essentially
carried out with modifications as described [39].
Three-month-old female Wistar rats (Harlan Laboratories/
Charles River; 191-230 grams, n = 13) were used to trans-
fect GM and SOL muscle. Both, left and right muscles were
injected with a reporter plasmid prior to electropulsing; the
right muscles only were also injected with plasmid for
native α and β CaMKII. pCDNA3 plasmids vectors encod-
ing full-length cDNA for α CaMKII (pCDNA3-CaMKIIα)
and β CaMKII (pCDNA3-CaMKIIβ) were a gift from Dr.
M Neal Waxham (University of Texas, Houston, USA).
The reporter plasmid encoding full-length luciferase under
control of 424 basepairs upstream of the transcription start
site of the chicken skeletal α-actin gene [59] was a gift from
Dr. Frank W. Booth (University of Missouri, Columbia,
USA). Animals were anaesthetized with 2-4% isoflurane
through inhalation. Hindlimbs were shaved, and skin was
disinfected with 70% ethanol. An incision was made into
the skin and fascia between GM and m. tibialis anterior.
SOL muscle was subsequently exposed and liberated, after
which four injections of a plasmid mixture with a
total volume of 90 μl were administered intramuscularly
with a 29-gauge insulin syringe. Subsequently four injec-
tions of a total volume of 180 μl were administered to the
GM along the length of the muscle. 5 minutes after DNA
injection, the muscles were subjected to electroporation as
established. 6-mm long needle electrodes (BD microlance
TM3, 27G 1⁄2″; distance 4 mm) were inserted perpendicu-
lar to the fibre orientation of the injected muscle and sub-
jected to discrete pulse protocols as established in previous
experiments. For SOL the protocol involved the delivery of
Eilers et al. BMC Physiology 2014, 14:7 Page 10 of 15
http://www.biomedcentral.com/1472-6793/14/73 trains of 80 ? 100 microsecond pulses at 100 mA, with
992 milliseconds of interrupt on 2 locations using needle
electrodes with a GET42EV generator (E.I.P. Electronique
et Informatique du Pilat, Jonzieux, France) [39]. For the
GM, this included the delivery of 8 trains of 60 ? 100
microsecond duration at 50 mA, with 994 milliseconds
interrupt on 3 locations. A mix of expression plas-
mid pCDNA3-CaMKIIα(0.22 μg μl−1) and pCDNA3-
CaMKIIβ(0.22 μg μl−1) in TBE buffer was injected
into muscles of the right leg together with the re-
porter plasmid (0.55 μg μl−1). Data obtained from
this reporter construct are beyond the scope of this
paper, and are therefore not reported. Muscles of the
left leg were injected with the reporter plasmid only
(1 μg μl−1). Right and left muscles of this experiment will
henceforth be referred to as ?α/β CaMKII-transfected? and
?control-transfected?, respectively. For the study of CaMKII
activation by isometric exercise in situ, both left and right
muscles were transfected with α/β CaMKII plasmid.
After electropulsing, the skin wound was closed with
sutures, and the animal was allowed to recover from
anaesthesia. Animals were kept in cages afterwards,
where they resumed normal activity within hours after
surgery. After seven days, animals were anaesthetized
for further measurement of contraction parameters
(see below) and euthanized by intra-cardiac injection
of Euthasol? (VU University Amsterdam) or anaesthetized
with 3% isoflurane and euthanized by dislocation of the
cervical vertebrae and rapid exsanguination (University
Hospital Bern). Treated muscles were harvested from both
legs and snap-frozen in liquid nitrogen.
In situ measures of muscle contraction
For measurement of isometric muscle contraction
parameters, rats were anaesthetized by intra-peritoneal
injections of 1.2 ml/100 gram body weight of 12.5%
urethane [60]. Ear and foot reflexes were tested to
check whether the animal was sufficiently anesthetized.
Subsequent injections of 0.3-0.5 ml, up to a maximum of
1.5 ml, were given every 10 min afterwards until reflexes
had disappeared. Experiments were carried out at room
temperature (24?C). Rats were kept on a heated pad to
prevent hypothermia. Hindlimbs were shaved and skin
was removed, after which GM and SOL muscles were
exposed and mechanically isolated by removing as much
as possible the myofascial connections to surrounding
muscles. Blood supply to, and nerve innervations of, both
muscles were kept intact and tendons of GM and SOL
muscles were attached to a force transducer via Kevlar
wires. The sciatic nerve was severed proximally and
connected to an external electrode that was controlled by
a computer to receive pulse wave stimulation.
Optimum length of the muscle-tendon complex
(the length of the muscle-tendon complex at whichmaximum tetanic force was produced) for isometric
contractions was first estimated using twitches, then
determined using a protocol consisting of two twitches
and one tetanic contraction (pulse duration 100 μsec,
tetanic stimulation frequency: 100 Hz, train duration:
400 ms [61]. Muscles were kept below slack length
between contractions and rest duration between maximal
contractions was approximately one minute. After
determination of optimum length, muscles rested for
five minutes. Subsequently, while muscles were set to
optimum length, a protocol of high-intensity exercise
(stimulation frequency: 100 Hz; train duration: 300 ms, one
train every 800 ms, 50 trains/contractions) was applied to
induce muscle fatigue. GM and SOL muscles were dis-
sected after the end of stimulation and snap-frozen in liquid
nitrogen. Animals were killed by intra-cardiac injec-
tion of Euthasol?, while still fully anaesthetized. Frozen
muscles were stored at -80?C until use for western
blotting/immunodetection and microscopic analysis as
described below.
Force data during muscle stimulation were sampled at
a frequency of 1000 Hz and collected using custom written
software based on Matlab (v 7.5.0, The Mathworks Inc.,
MA, USA). Time-to-peak-twitch force, half-relaxation time,
maximum twitch force and maximum tetanic force were
determined. The same contraction parameters were
determined for a group of non-transfected muscles
(NT; SOL/GM, n = 8). Values obtained for the two
twitch values in each trace were averaged.
Isometric exercise in situ
A two-minute stimulation protocol consisting of intermit-
tent isometric tetanic contractions of GM muscle at 100 Hz
stimulation frequency [27] was applied via the sciatic nerve
to α/β-CaMKII-transfected SOL muscle in situ. The stimu-
lated muscles (n = 6) were freeze-clamped between liquid
nitrogen-cooled aluminium grips during stimulation after
two minutes. Non-stimulated, α/β-CaMKII-transfected
contra-lateral muscles were subsequently dissected and
frozen in liquid nitrogen. Proteins were extracted from the
muscle and subjected to SDS-PAGE followed by western
blotting and immunodetection as described below.
Protein biochemistry
Western blotting/immunodetection
To analyse protein expression, frozen 25 μm thick
cross-sections taken from the centre portion of the
muscle were homogenized in ice-cold RIPA buffer
(50 mM TRIS-HCl (pH 7.5), 150 mM NaCl, 1 mM
EDTA, 1% v/v Nonidet P40 substitute, 0.25% w/v sodium
deoxycholate) plus freshly added protease/phosphatase
inhibitors: 1 mM NaF, 1 mM Na3VO4, 0.1 mM PMSF,
1 μg ml−1 leupeptin, 0.2 μg ml−1 pepstatin, 0.1 μg ml−1
aprotinin, using a Polytron homogenizer (Kinematica,
Eilers et al. BMC Physiology 2014, 14:7 Page 11 of 15
http://www.biomedcentral.com/1472-6793/14/7Luzern, Switzerland). Chemicals were obtained from
Sigma-Aldrich (Dorset, United Kingdom). Crude homoge-
nates were aspirated 5-10 times through a 0.8 mm syringe
needle, and stored at -80?C until use for analysis. An
aliquot of the aspirated homogenate was taken for deter-
mination of protein concentration with the bicinchoninic
acid protein assay (Pierce, Rockford IL, USA).
Protein levels of total CaMKII and pThr287-CaMKII were
analysed by western blotting followed by immunodetection.
Homogenates were denatured by addition of SDS-PAGE
buffer (final concentration: 50 mM TRIS-HCl (pH 6.8),
2% w/v bromophenol blue, 10% v/v glycerol, 2% β-
mercaptoethanol) and five minutes heating at 95?C.
20-40 μg of protein was separated by SDS-PAGE and
transferred overnight onto a nitrocellulose membrane
(GE Healthcare, Little Chalfont, UK). Membranes were
stained with Ponceau S solution to confirm equal protein
loading and transfer. The membrane was blocked in 5%
skimmed milk in TRIS-buffered saline (pH 7.4) with
0.05% Tween-20 (TBS-T), followed by incubation with a
primary antibody for pan-CaMKII (BD Bioscience
#611292, dilution: 1/2500), pThr287-CaMKII (Cell
Signalling Technology #3361, dilution: 1/1000), fast
myosin heavy chain (Sigma-Aldrich #M4276, dilution
1/1000), myogenin (Santa Cruz Biotechnology, sc-12732
(F5D); 1:200) or myoD (Santa Cruz Biotechnology, sc-304;
1:200) or OxPhos proteins (succinate dehydrogenase Fp
subunit (SDHA), ATP synthase subunit α (ATP5A),
ubiquinol cytochrome c oxioreductase subunit 2 (UQCRC2)
and NADH ubiquinone oxidoreductase subunit 9
(NDUFA9); #458199, Invitrogen, dilution 1/1000, and
COXIV (#4850, Cell Signalling Technology, 1/2000))
for 2 hours. Antibody incubation solutions were 5%
milk or 5% bovine serum albumin (BSA) in TBS-T.
Finally, membranes were incubated with species-specific
horseradish peroxidase-conjugated secondary antibodies
(Millipore, Watford, UK). Membranes were washed in
TBS-T for 4 ? 5 minutes after both antibody incubations.
Antibodies were detected with an enhanced chemilumin-
escence kit (Pierce, Rockford IL, USA). Light signals were
captured with a ChemiDoc XRS system (Biorad, Hemel
Hempstead, UK).
Transfected muscle pairs from the same animal were run
on the same blot. Measures were limited to animals whose
CaMKII injected & porated muscles showed increased
expression in either of the exogenous CaMKII isoforms on
a western blot. Protein bands were quantified with Quantity
One version 4.6.8 (Biorad). These values were subsequently
expressed as relative to the mean of the control-transfected
muscles for the respective immunoblot.
Establishing CaMKII detection
To identify CaMKII isoforms in skeletal muscle [41]
buffer components were added to muscle homogenateto promote, or suppress, calcium/calmodulin dependent
protein phosphorylation in vitro as described [62]. The
reaction products were subjected to SDS-PAGE and
immunoblotted for CaMKII as described in the section on
?western blotting and immunodetection? below. CaMKII
isoforms were labelled in reference to a previous report
[41]. The phosphorylated form of exogenous β CaMKII
was identified based on its molecular weight (60.4 kDa),
which is very similar to that of δa (60.1 kDa), the second
largest CaMKII isoform in skeletal muscle [29].
Microscopic analysis
To investigate differences in protein expression at the single
fibre level, immunofluorescent staining was performed on
cryosections of transfected muscles. Sections (12 μm thick-
ness) were cut on a cryostat (CM3050, Leica, Germany)
and dried for 30 minutes on glass slides. Sections were then
fixed with ice-cold acetone and blocked with 5% normal
goat serum in phosphate buffered saline, pH 7.5 (PBS).
CaMKII and SERCA2, COXIV, MHCI or MHCII, were
detected simultaneously using commercially available
primary antibodies (anti-CaMKII; anti-SERCA2 (Abcam
#Ab3625 or Abcam #2A7-A1, dilution 1/200); anti-
COXIV (#4850, Cell Signalling Technology); anti-MHCI
(#MAB1628, Millipore, dilution 1/100); anti-MHCII
(#M4277, Sigma Chemicals, dilution 1/100) and species-
specific Alexa 488/555 secondary antibodies (Invitrogen).
Sections were washed with PBS for 4 ? 5 minutes after
both antibody incubations. To detect nuclei, sections
were incubated for 10 minutes with TO-PRO-3 iodide
(Invitrogen, Paisley, UK). Immuno-labelled sections were
embedded in fluorescence compatible mounting medium
(DAKO, Ely, UK).
Protein expression in electroporated fibres was analysed
on a TCS SP5 confocal microscope (Leica, Milton Keynes,
UK). A 10? objective was used in combination with
4? optical zoom. The fluorescent labels were excited
with an Argon laser at 488 nm and HeNe lasers at
543 nm and 633 nm. The pinhole was set to match
the thickness of the stained section and the focus
plane was adjusted to maximize signal detection. Dyes
were excited separately using a sequential scanning
mode. Detected light spectra were set to maximize
signal detection, but care was taken to prevent cross-
excitation of dyes. Laser intensity was set to produce
images with few under- or overexposed pixels, and
low levels of non-specific staining, as indicated by
light emission from sections that had been labelled
with the secondary antibodies only. 8-Bit images were
captured at 2048 ? 2048 pixels, using 100 Hz scanning
speed and 5-times line averaging.
The efficiency of overexpression was estimated by
taking a tile scan of one cryosections of the belly portion of
each α/β CaMKII-transfected muscle, which was stained




PCR primer sequence 5 ?→ 3 ? Genbank
18S RNA Forward: CGAACGTCTGCCCTATCAACTT EU 139318.1
Reverse: ACCCGTGGTCACCATGGTA
COXI Forward: TGCCAGTATTAGCAGCAGGT X14848.1
Reverse: GAATTGGGTCTCCACCTCCA
COXIV Forward: AGTCCAATTGTACCGCATCC NM 017202.1
Reverse: ACTCATTGGTGCCCTTGTTC
SDHB Forward: CAGAGAAGGGATCTGTGGCT NM 001100539.1
Reverse: TGTTGCCTCCGTTGATGTTC
PGC-1α Forward: ATGAGAAGCGGGAGTCTGAA NM 031347.1
Reverse: GCGCTCTTCAATTGCTTTCT
SERCA2A Forward: GGCCCGAAACTACCTGGAGCC NM 001110139
Reverse: CAACGCACATGCACGCACCC
CAV3 Forward: CCCAAGAACATCAATGAGGAC U31968
Reverse: GGAGACGGTGAAAGTGGTGT
DYSF Forward: TGGGAACCGCTACCATCTAC NM001107869
Reverse: CTCTGGTGCAGGAAGGAGAC
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staining. Subsequently individual microscopic fields were
assessed for the number of fibres with prominent staining
for CaMKII and the total fiber number. On average 234
and 386 fibres were counted for SOL and GM muscle,
respectively. MCSA of transfected and non-transfected
fibres was estimated in colorimetrically stained cross
sections using Adobe Photoshop CC (Adobe Systems
Incorporated) in regions of α/β CaMKII-transfected SOL
muscle as described [63]. Only fibres which met the criteria
of a circularity factor >0.5 were included. On average 30
transfected and 60 non-transfected fibres from the same
transfected region were assessed per cross section.
SERCA2, COXIV and CaMKII staining intensity in
muscle fibres overexpressing CaMKII (identified based
on CaMKII staining intensity by visual inspection) was
quantified with ImageJ (rsbweb.nih.gov/ij/). Fibres were
circumscribed manually and the average pixel intensity
within the fibre was measured. An approximately equal
number of fibres in the same image which did not
demonstrate elevated CaMKII content (designated
? non-transfected fibers ? ) was measured as well, and
acted as the control group of fibres to which the
CaMKII-overexpressing fibres (designated ? transfected
fibers? ) were compared. MHCII expression in transfected
and non-transfected fibers was assessed in the transfected
region based on the presence or absence of MHC-staining
as this staining was rather discrete than continuous.
Fibres with internal nuclei were assessed on 12-μm
cryosections being stained with and counterstained with
hematoxylin (MERCK, Germany). Microscopic files were
taken at a 10-fold magnification (Axioskop 2, Carl Zeiss
Ltd, Welwyn Garden City, UK) and assembled with
AxioVision software (Carl Zeiss Ltd). Subsequently a grid
with 250-μm unit length was superimposed and micro-
scopic fields corresponding to 0.0625 μm2 were assessed in
a random initiation, systematic manner counting fibre
profiles and fibre profiles with internal (blue) nuclei.
On average 475 + 50 fibre were counted per muscle.
RT-PCR
RNA extraction from muscle tissue and RT-PCR analysis
were carried out as described elsewhere [64]. Total RNA
was extracted from frozen 25 μm-sections of transfected
SOL muscles using the RiboPure kit (Applied Biosystems).
RNA concentration and purity (260/280 nm ratio; mean:
2.06, range: 1.92-2.09) were determined using a spectro-
photometer (Nanodrop Technologies, Wilmington, DE).
Total RNA concentration in muscle tissue was expressed
as RNA (ng) per weight of the analysed sample (mg). Five
hundred nanogram of total RNA per muscle was reverse-
transcribed using the high capacity RNA-to-cDNA kit
(Applied Biosystems) containing random primers in a
20 μl total reaction volume. Tubes were heated at 25?C for5 min, followed by 42?C for 30 min. Finally; the tubes were
heated to 85?C for 5 min to stop the reaction and
stored at -80?C until used in the PCR reaction.
For each PCR target, 5 μl of the RT reaction product was
amplified in duplicate using Fast Sybr Green mastermix
(Applied Biosystems). The following transcripts were
targeted: 18S ribosomal RNA (18S rRNA), caveolin 3
(CAV3), dysferlin (DYSF), cytochrome-c oxidase subunit 1
(COXI), cytochrome-c oxidase 4 (COXIV), succinate
dehydrogenase subunit b (SDHB), peroxisome proliferator-
activated receptor γ-co-activator 1 α (PGC-1α), Annexin V
(ANXV), and SERCA2A. PCR primers were designed
using Primer-BLAST (http://www.ncbi.nlm.nih.gov/tools/
primer-blast/). Primer sequences and Genbank accession
numbers for the transcripts are shown in Table 2.
Amplification efficiency of the primers used was
92.7-102.0%, and melting curve analysis demonstrated
specific amplification. The range of cycle threshold
values was 13-25. For all transcripts, the 18S rRNA cycle
threshold was subtracted from the mean cycle threshold
value of the specific target to obtain ΔCt and converted
into relative concentrations by 2-ΔCt.
Statistics
Statistical analyses were carried out with STATISTICA
for windows (V10.0, StatSoft, Inc. (2011), www.statsoft.com)
or SPSS16 (SPSS Inc, IL, USA). One sample was identified
as an outlier in the RT-PCR experiments based on the
Grubb ? s test and excluded from the further analysis.
Immunofluorescence data from fibres demonstrating
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CaMKII-transfected? muscle were analysed with two-tailed
t-tests (unpaired). The fractions of MHCII-positive muscle
fibres in the α/β CaMKII-transfected and non-transfected
fibre pool, respectively, were analysed with Chi-squared
tests because they represent categorical values. Western
blot/immunodetection data from ?control-transfected? and
?α/β CaMKII-transfected ? muscles were analysed with
two-tailed Wilcoxon signed ranks tests. The effect of
transfection on twitch and tetanic force parameters
from ?α/β CaMKII-transfected ? and ? control-trans-
fected ? muscles was tested by relating force values to
the respective mean of measures from the respective
? non-transfected muscles (i.e. GM and SOL) and running an
ANOVA for the factors muscle (SOL, GM) x transfection
(CaMKII-transfected, control-transfected). Non-parametric
tests were run with exact significance. Significance
level was set at p <0.05. Values are provided as mean ?
standard error (SE).
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